Publish in this journal
Journal Information
Vol. 48. Issue 1.
Pages 33 (January 2012)
Vol. 48. Issue 1.
Pages 33 (January 2012)
Letter to the Editor
DOI: 10.1016/j.arbr.2011.11.004
Full text access
Julio Sánchez de Cos Escuína,??
Corresponding author

Corresponding author.
, Jesús Hernández Hernándezb, Marcelo Jiménez Lópezc, Susana Padrones Sánchezd, Antoni Rosell Gratacósd, Ramón Rami Portae
a Sección de Neumología, Hospital San Pedro de Alcántara, Cáceres, Spain
b Sección de Neumología, Hospital Nuestra Señora de Sonsoles, Ávila, Spain
c Servicio de Cirugía Torácica, Hospital Universitario de Salamanca, Salamanca, Spain
d Servicio de Neumología, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
e Servicio de Cirugía Torácica, Hospital Universitario Mutua de Terrassa, Terrassa, Barcelona, Spain
Related content
Arch Bronconeumol. 2011;47:454-6510.1016/j.arbr.2011.06.007
Julio Sánchez de Cos, Jesús Hernández Hernández, Marcelo F. Jiménez López, Susana Padrones Sánchez, Antoni Rosell Gratacós, Ramón Rami Porta
Article information
Full Text
Download PDF
Full Text
Dear Editor,

We have read with great interest the recent comments regarding the SEPAR Guidelines for lung cancer staging.1 We agree with your comments about the inaccessibility of the lymph nodes at station 5 using EBUS. Although our study affirms the inaccessibility of station 6 using EBUS and EUS, there may be confusion about station 5. Some early publications confirm the accessibility of this station by means of EBUS,2 but later articles, published after drafting our guidelines, have clarified that this was due to a possible confusion between stations 4L and 5.3,4 Thus, we agree with the need for surgical techniques to reach said station.

With regards to the meta-analysis by Gu et al.,5 we believe that, despite the limitations of some of the studies included, the authors are able to recognize these, including the possible confusions regarding station 5, which is thus expressed in their article. As for the negative predictive value (NPV) of EBUS and EUS, as has usually happened with the advent of new procedures, it is possible that the excellent results reported by the first authors are optimistic and it will be necessary to wait for the communication of other related experiences.6 For a proper evaluation of the performance of EBUS and EUS, many aspects need to be considered. Not only the “gold standard” method of confirmation, which is ideally as rigorous as possible, but also, among others, some that are quite important such as the details entailed with the execution of the procedure (number of biopsies per lymph node, presence or absence of cytopathologist in situ), experience of the team and patient selection criteria that determine the prevalence of mediastinal lymph node affectation.

Finally, we would like to acknowledge the comments expressed in said letter as we believe that they contribute to specifying the reach and the limitations of a technique that is providing important advances in lung cancer staging.

J. Sánchez de Cos, J. Hernández Hernández, M. Jiménez López, S. Padrones Sánchez, A. Rosell Gratacós, R. Rami Porta.
Normativa SEPAR sobre estadificación del carcinoma de pulmón.
Arch Bronconeumol, 47 (2011), pp. 454-465
F. Herth, H.D. Becker, A. Ernst.
Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial.
Chest, 125 (2004), pp. 322-325
A. Szlubowski, J. Kuzdzal, M. Kolodziej, J. Soja, J. Pankowski, A. Obrochta, et al.
Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging.
Eur J Cardiothoracic Surg, 35 (2009), pp. 332-335
R.J. Cerfolio, A.S. Bryant, M.A. Eloubeidi, P.A. Frederick, D.J. Minninch, K.C. Harbour, et al.
The true false-negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer.
Ann Thorac Surg, 90 (2010), pp. 427-434
P. Gu, Y.Z. Zhao, L.Y. Jiang, W. Zhang, Y. Xin, B.H. Han.
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis.
Eur J Cancer, 45 (2009), pp. 1389-1396
M.L. Tedde.
The true false-negative rates of EBUS and EUS.
Ann Thorac Surg, 91 (2011), pp. 1653-1654

Please cite this article as: Sánchez de Cos Escuín J, et al. Réplica. Arch Bronconeumol. 2011;48:33.

Copyright © 2011. SEPAR
Archivos de Bronconeumología (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?